Baxter International’s Novum IQ syringe infusion pump cleared by FDA
September 1, 2022
Trending News ☀️
The U.S. FDA’s clearance of Baxter International($NYSE:BAX)’s Novum IQ syringe infusion pump with Dose IQ Safety Software opens up new possibilities for the company in the medical device market. The pump is designed to deliver small amounts of fluid at low rates, usually in pediatric, neonatal or anesthesia care settings. This could potentially increase Baxter’s earnings in the long term, as the pump provides a new option for patients and care providers.
Stock Price
On Wednesday, Baxter International’s stock opened at $57.3 and closed at $57.5, up by 1.7% from its previous closing price of 56.5. The Novum IQ pump is a next-generation device that is designed to improve patient safety and reduce the risk of medication errors. The pump can be programmed to deliver a wide range of infusion rates, and features an integrated barcode scanner that helps to ensure accuracy. Baxter is a global leader in infusion therapy and pain management, and the Novum IQ pump is a significant addition to its product portfolio. With its clearance by the FDA, the pump is now available for use in the United States.
VI Analysis
Baxter International is a large medical device company with a long history. Its products are used in hospitals and clinics around the world.
However, the company has been facing challenges in recent years. Its stock price has been volatile, and it has been involved in several lawsuits. The company’s fundamentals reflect its long term potential.
However, based on the VI Risk Rating, Baxter International is a high risk investment in terms of financial and business aspects. There are potential risks in the company’s business and financial areas.
Summary
The pump is intended for use with various pharmaceuticals and medical devices. The pump is designed to provide accurate and consistent infusion rates for various pharmaceuticals and medical devices. The pump is also intended to reduce the risk of medication errors and improve patient safety. The pump represents a new standard of safety and efficacy for syringe infusion pumps. The pump will help to improve patient care and reduce the risk of medication errors.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
